Share on StockTwits

Neuralstem (NYSE:CUR) Insider Karl Johe unloaded 6,000 shares of the company’s stock on the open market in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $4.09, for a total value of $24,540.00. Following the completion of the transaction, the insider now directly owns 495,747 shares in the company, valued at approximately $2,027,605. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Neuralstem (NYSE:CUR) traded down 3.23% on Wednesday, hitting $3.90. The stock had a trading volume of 648,826 shares. Neuralstem has a 52-week low of $1.60 and a 52-week high of $4.81. The stock’s 50-day moving average is $3.39 and its 200-day moving average is $3.77. The company’s market cap is $338.7 million.

Neuralstem (NYSE:CUR) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.08) earnings per share for the quarter, missing the analysts’ consensus estimate of ($0.05) by $0.03. On average, analysts predict that Neuralstem will post $-0.22 earnings per share for the current fiscal year.

CUR has been the subject of a number of recent research reports. Analysts at Aegis reiterated a “buy” rating on shares of Neuralstem in a research note on Friday, August 8th.

Neuralstem, Inc is a development-stage company focused on the development and commercialization of treatments for central nervous system disease based on transplanting human neural stems cells and the use of small molecule drugs.

Receive News & Ratings for Neuralstem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuralstem Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.